Cardiovascular events after exacerbations of chronic obstructive pulmonary disease: Results from the EXAcerbations of COPD and their OutcomeS in CardioVascular diseases study in Italy
- PMID: 38729787
- DOI: 10.1016/j.ejim.2024.04.021
Cardiovascular events after exacerbations of chronic obstructive pulmonary disease: Results from the EXAcerbations of COPD and their OutcomeS in CardioVascular diseases study in Italy
Abstract
Introduction: Exacerbations of chronic obstructive pulmonary disease (COPD) can increase the risk of severe cardiovascular events.
Objective: Assess the crude incidence rates (IR) of cardiovascular events and the impact of exacerbations on the risk of cardiovascular events within different time periods following an exacerbation.
Methods: COPD patients aged ≥45 years between 01/01/2015 and 12/31/2018 were identified from the Fondazione Ricerca e Salute administrative database. IRs of severe non-fatal and fatal cardiovascular events were obtained for post-exacerbation time periods (1-7, 8-14, 15-30, 31-180, 181-365 days). Time-dependent Cox proportional hazard models compared cardiovascular risks between periods with and without exacerbations.
Results: Of 216,864 COPD patients, >55 % were male, mean age was 74 years, frequent comorbidities were cardiovascular, metabolic and psychiatric. During an average 34-month follow-up, 69,620 (32 %) patients had ≥1 exacerbation and 46,214 (21 %) experienced ≥1 cardiovascular event. During follow-up, 55,470 patients died; 4,661 were in-hospital cardiovascular-related deaths. Among 10,269 patients experiencing cardiovascular events within 365 days post-exacerbation, the IR was 15.8 per 100 person-years (95 %CI 15.5-16.1). Estimated hazard ratios (HR) for the cardiovascular event risk associated with periods post-exacerbation were highest within 7 days (HR: 34.3, 95 %CI: 33.1-35.6), especially for heart failure (HR 50.6; 95 %CI 48.6-52.7) and remained elevated throughout 365 days (HR 1.1, 95 %CI 1.02-1.13).
Conclusions: COPD patients in Italy are at high risk of severe cardiovascular events following exacerbations, suggesting the need to prevent exacerbations and possible subsequent cardiovascular events through early interventions and treatment optimization.
Keywords: Cardiovascular diseases; Chronic obstructive pulmonary disease; Disease exacerbations; Proportional Hazards Models; Public Health.
Copyright © 2024. Published by Elsevier B.V.
Conflict of interest statement
Declaration of competing interest APM received personal fees for the participation in clinical studies supported by Bayer, Novartis, Sanofi and Astra Zeneca, outside the present work. PR participated as a lecturer and advisor in scientific meetings and courses under the sponsorship of Almirall, AstraZeneca, Biofutura, Boehringer Ingelheim, Chiesi Farmaceutici, GlaxoSmithKline, Menarini Group, Mundipharma, and Novartis, and her department was funded by Almirall, Boehringer Ingelheim, Chiesi Farmaceutici Novartis, and Zambon. FD received payment or honoraria for lectures, presentations, speaker bureaus, manuscript writing or educational events from Alfa Wassermann, Alfasigma, AstraZeneca, Bayer, Boehringer, BMS/Pfizer, Daiichi Sankyo, IL, GSK, Menarini, Novartis, Sandoz, Sanofi, Tillots Pharma AG. CN is an AstraZeneca employee and declares that her collaboration to this manuscript reflects only personal opinions. KR is an AstraZeneca employee and shareholder and declares that her collaboration to this manuscript reflects only personal opinions. The other authors declare no conflict of interest.
Similar articles
-
Increased Risk of Severe Cardiovascular Events Following Exacerbations of Chronic Obstructive Pulmonary Disease: Results of the EXACOS-CV Study in Japan.Adv Ther. 2024 Aug;41(8):3362-3377. doi: 10.1007/s12325-024-02920-y. Epub 2024 Jul 8. Adv Ther. 2024. PMID: 38976123 Free PMC article.
-
Heightened long-term cardiovascular risks after exacerbation of chronic obstructive pulmonary disease.Heart. 2024 Apr 25;110(10):702-709. doi: 10.1136/heartjnl-2023-323487. Heart. 2024. PMID: 38182279 Free PMC article.
-
Chronic Obstructive Pulmonary Disease Exacerbations Increase the Risk of Subsequent Cardiovascular Events: A Longitudinal Analysis of the COPDGene Study.J Am Heart Assoc. 2024 Jun 4;13(11):e033882. doi: 10.1161/JAHA.123.033882. Epub 2024 May 31. J Am Heart Assoc. 2024. PMID: 38818936 Free PMC article.
-
Temporal Dynamics of Cardiovascular Risk in Patients with Chronic Obstructive Pulmonary Disease During Stable Disease and Exacerbations: Review of the Mechanisms and Implications.Int J Chron Obstruct Pulmon Dis. 2024 Oct 10;19:2259-2271. doi: 10.2147/COPD.S466280. eCollection 2024. Int J Chron Obstruct Pulmon Dis. 2024. PMID: 39411574 Free PMC article. Review.
-
Immunostimulants versus placebo for preventing exacerbations in adults with chronic bronchitis or chronic obstructive pulmonary disease.Cochrane Database Syst Rev. 2022 Nov 14;11(11):CD013343. doi: 10.1002/14651858.CD013343.pub2. Cochrane Database Syst Rev. 2022. PMID: 36373977 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical